SUNLIGHT-INDUCED decontamination of water from emerging pharmaceutical pollutants using ZnO nanoparticles

Abstract

A new class of environmental pollutants that have become a significant concern for the entire world's population over the last few decades are pharmaceutical contaminants due to the potential risks they pose to the environment and human health. An investigation on the photocatalytic degradation of four different model pharmaceutical contaminants: Tetracycline (TCT), Sulfamethoxazole (SMX), Chloroquine (CLQ), and Diclofenac (DCF) has been carried out using ZnO nanoparticles as the photocatalyst, and sunlight as the source of energy in a batch photocatalytic reactor. This process resulted in the degradation of about 51% for TCT, 65% for SMX, 61% for CLQ, and 55% for DCF within 30 min of solar irradiation. Complete degradation and COD reduction were achieved after a prolonged irradiation. The slow decay is attributed to the evolution of the intermediate compounds, which were identified using the liquid chromatography quadrupole time-of-flight mass spectrometry (LC-Q-TOF-MS) method. The possible intermediates formed were identified for each molecule (i.e., TCT having 6 products, SMX, having 4 products, DCF having 8 products and CLQ having 8 products), and the mechanism for each pollutant is proposed. The effect on distinct operational parameters, like catalyst loading, and pH, environmentally relevant parameters such as ionic effect, and multiple contaminants system were investigated. It was found that the anions such as Cl−, SO42−, CO32−, HCO3−, NO3−, F−, Br−, and I−both individually as well as in combination had no effect on the degradation except for SMX. For multiple component systems, when two pollutants are mixed, each pollutant affects the degradation of the other and in the case of CLQ/TCT system, CLQ inhibits the degradation of TCT drastically. The study demonstrates that ZnO is an effective and convenient option for photocatalytic decontamination of water sources contaminated with a variety of pharmaceutical contaminants.